Abstract:Astrocytes are the most abundant cells in the central nervous system (CNS). Under neurodegenerative conditions, astrocytes can go through various morphological and functional changes and then transform into reactive forms. Therefore, compared with normal physiological conditions, the expression and distribution of many cellular molecules in reactive astrocytes show significant changes. It will be of great benefit for research and clinical practice if these molecular alterations of astrocytes can be used as biomarkers for the study of neurodegenerative diseases. In this chapter, we will comprehensively introduce some potential biomarkers involving various aspects of activated astrocytes, including structural and functional characteristics, and their participation in neuroinflammatory responses, such as GFAP, glutamate transporters, and S100 beta. We will analyze the advantages and limitations of traditional biomarkers of reactive astrocytes, such as GFAP, and provide some insights into potentially novel biomarkers. Then we will give a brief introduction of potential biomarkers in some typical neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS). Finally, we provide some methods applied in biomarker studies for reference. These methods range from astrocyte isolating, culture, and further biomarker analysis to clinical techniques such as molecular imaging. In the future, advances in the detection of biomarkers in astrocytes under neurodegenerative conditions will not only shed light on early diagnosis but also be illuminating in the treatment of neurodegenerative diseases, which is still in a rather difficult stage, by serving as potential targets for drugs. More analyses of astrocytes based on these biomarkers and a deeper understanding of the molecular pathogenesis of neurodegenerative diseases will undoubtedly bring hope to individual patients, their families, and the whole society as well.

Reactive Astrocytes in Neurodegenerative Diseases

Signaling Pathways Regulating Neuron–glia Interaction and Their Implications in Alzheimer's Disease

Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.

Astrocytes: a double-edged sword in neurodegenerative diseases

Functional roles of reactive astrocytes in neuroinflammation and neurodegeneration

Revisiting the critical roles of reactive astrocytes in neurodegeneration

Protective Functions of Reactive Astrocytes Following Central Nervous System Insult

Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies

Astrocytes: biology and pathology

Astrocyte-Mediated Neuroinflammation in Neurological Conditions

The Diverse Roles of Reactive Astrocytes in the Pathogenesis of Amyotrophic Lateral Sclerosis

Emerging Roles of Astrocytes in Neuro-Vascular Unit and the Tripartite Synapse with Emphasis on Reactive Gliosis in the Context of Alzheimer’s Disease

Reactive astrocyte nomenclature, definitions, and future directions

Reactive astrocytes generated from human iPSC are pro-inflammatory and display altered metabolism

Activation of Astrocytes in Neurodegenerative Diseases

Neurotoxic reactive astrocytes are induced by activated microglia

Reactive astrogliosis in the era of single-cell transcriptomics

Functions of Astrocytes under Normal Conditions and after a Brain Disease

MicroRNA-mediated regulation of reactive astrocytes in central nervous system diseases

The dual role of astrocyte activation and reactive gliosis

Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimer'S Disease